Using a single-cell analysis approach, we identified a significant over-expression of all four OATP isoforms by the myeloid cells within GBM tumor tissue, with the proportion of total IBA1+ cells positive for OATP immunoreactivity being greater than 90% (Supplementary Figure S9). The gene discussed is SLCO1A2; the disease is neoplasm.